Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment
Introduction: Female pattern hair loss (FPHL) is one of the most common forms of diffuse alopecia in females.. Despite the availability of multiple treatment options, FPHL management poses challenges for the dermatologist. Objectives: We aimed to compare the efficacy and safety of topical finaste...
Saved in:
| Main Authors: | Naglaa Mohamed El Sayed, Eman Hamed Elmorsy, Tarek Mahmoud Hussein, Eman Hassan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mattioli1885
2025-01-01
|
| Series: | Dermatology Practical & Conceptual |
| Subjects: | |
| Online Access: | https://dpcj.org/index.php/dpc/article/view/4698 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss
by: Rachel C Hill, et al.
Published: (2025-07-01) -
A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds
by: Saedah Dereiah, et al.
Published: (2024-12-01) -
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants
by: Amira Soliman, et al.
Published: (2025-03-01) -
Effect of spironolactone on monocyte subsets in atrial fibrillation: IMPRESS-AF randomised controlled trial
by: Farhan Shahid, et al.
Published: (2025-07-01) -
ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01)